p.122 抽出テキスト

anxiety and depression in patients with coronary heart disease: results from the EUROASPIRE V cross-sectional survey. Eur J Cardiovasc Nurs 2023;22:719–29. https://doi.org/10.1093/eurjcn/zvac105 1143. Chiang CY, Choi KC, Ho KM, Yu SF. Effectiveness of nurse-led patient-centered care behavioral risk modification on secondary prevention of coronary heart disease: a systematic review. Int J Nurs Stud 2018;84:28–39. https://doi.org/10.1016/j.ijnurstu. 2018.04.012 1144. O’Connor EA, Evans CV, Rushkin MC, Redmond N, Lin JS. Behavioral counseling to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2020;324:2076–94. https:// doi.org/10.1001/jama.2020.17108 1145. Garcia-Lunar I, van der Ploeg HP, Fernandez Alvira JM, van Nassau F, Castellano Vázquez JM, van der Beek AJ, et al. Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial. Eur Heart J 2022;43:3732–45. https://doi.org/10.1093/eurheartj/ehac378 1146. Gandhi S, Chen S, Hong L, Sun K, Gong E, Li C, et al. Effect of mobile health interventions on the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Can J Cardiol 2017;33:219–31. https://doi.org/10.1016/j.cjca.2016.08. 017 1147. Akinosun AS, Polson R, Diaz-Skeete Y, De Kock JH, Carragher L, Leslie S, et al. Digital technology interventions for risk factor modification in patients with cardiovascular disease: systematic review and meta-analysis. JMIR Mhealth Uhealth 2021;9:e21061. https://doi.org/10.2196/21061 1148. Kaihara T, Intan-Goey V, Scherrenberg M, Falter M, Frederix I, Dendale P. Impact of activity trackers on secondary prevention in patients with coronary artery disease: a systematic review and meta-analysis. Eur J Prev Cardiol 2022;29:1047–56. https://doi. org/10.1093/eurjpc/zwab146 1149. Patterson K, Davey R, Keegan R, Freene N. Smartphone applications for physical activity and sedentary behaviour change in people with cardiovascular disease: a systematic review and meta-analysis. PLoS One 2021;16:e0258460. https://doi.org/10. 1371/journal.pone.0258460 1150. Du L, Cheng Z, Zhang Y, Li Y, Mei D. The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis. Eur J Prev Cardiol 2017;24: 962–70. https://doi.org/10.1177/2047487317695628 1151. Sanfélix-Gimeno G, Peiró S, Ferreros I, Pérez-Vicente R, Librero J, Catalá-López F, et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain. J Manag Care Pharm 2013;19: 247–57. https://doi.org/10.18553/jmcp.2013.19.3.247 1152. Garcia RA, Spertus JA, Benton MC, Jones PG, Mark DB, Newman JD, et al. Association of medication adherence with health outcomes in the ISCHEMIA trial. J Am Coll Cardiol 2022;80:755–65. https://doi.org/10.1016/j.jacc.2022.05.045 1153. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014;2014:CD000011. https://doi.org/10.1002/14651858.CD000011.pub4 1154. Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med 2017;99:269–76. https://doi.org/10. 1016/j.ypmed.2017.03.008 1155. Fuller RH, Perel P, Navarro-Ruan T, Nieuwlaat R, Haynes RB, Huffman MD. Improving medication adherence in patients with cardiovascular disease: a systematic review. Heart 2018;104:1238–43. https://doi.org/10.1136/heartjnl-2017-312571 1156. Cross AJ, Elliott RA, Petrie K, Kuruvilla L, George J. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications. Cochrane Database Syst Rev 2020;5:CD012419. https://doi.org/10.1002/ 14651858.CD012419.pub2 1157. Mahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev 2011;9:CD005025. https://doi.org/10.1002/14651858.CD005025.pub3 1158. Lapa ME, Swabe GM, Rollman BL, Muldoon MF, Thurston RC, Magnani JW. Assessment of depression and adherence to guideline-directed medical therapies following percutaneous coronary intervention. JAMA Netw Open 2022;5:e2246317. https://doi.org/10.1001/jamanetworkopen.2022.46317 1159. Schmieder RE, Wassmann S, Predel HG, Weisser B, Blettenberg J, Gillessen A, et al. Improved persistence to medication, decreased cardiovascular events and reduced all-cause mortality in hypertensive patients with use of single-pill combinations: results from the START-study. Hypertension 2023;80:1127–35. https://doi.org/10. 1161/HYPERTENSIONAHA.122.20810 1160. Simon ST, Kini V, Levy AE, Ho PM. Medication adherence in cardiovascular medicine. BMJ 2021;374:n1493. https://doi.org/10.1136/bmj.n1493 1161. Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, et al. Effects of a fixeddose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA 2013;310:918–29. https:// doi.org/10.1001/jama.2013.277064 1162. Jeong SM, Kim S, Wook Shin D, Han K, Hyun Park S, Hyuk Kim S, et al. Persistence and adherence to antihypertensive drugs in newly treated hypertensive patients according to initial prescription. Eur J Prev Cardiol 2021;28:e1–4. https://doi.org/10. 1177/2047487319900326 1163. Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, et al. Polypill strategy in secondary cardiovascular prevention. N Engl J Med 2022;387: 967–77. https://doi.org/10.1056/NEJMoa2208275 1164. Adler AJ, Martin N, Mariani J, Tajer CD, Owolabi OO, Free C, et al. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2017;4:CD011851. https://doi.org/10. 1002/14651858.CD011851.pub2 1165. Kassavou A, Mirzaei V, Brimicombe J, Edwards S, Massou E, Prevost AT, et al. A highly tailored text and voice messaging intervention to improve medication adherence in patients with either or both hypertension and type 2 diabetes in a UK primary care setting: feasibility randomized controlled trial of clinical effectiveness. J Med Internet Res 2020;22:e16629. https://doi.org/10.2196/16629 1166. Castellano JM, Sanz G, Penalvo JL, Bansilal S, Fernández-Ortiz A, Alvarez L, et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol 2014;64:2071–82. https://doi.org/10.1016/j.jacc.2014.08.021 1167. Wilson PW, D’Agostino R Sr, Bhatt DL, Eagle K, Pencina MJ, Smith SC, et al. An international model to predict recurrent cardiovascular disease. Am J Med 2012;125: 695–703.e1. https://doi.org/10.1016/j.amjmed.2012.01.014 1168. De Bacquer D, Ueda P, Reiner Z, De Sutter J, De Smedt D, Lovic D, et al. Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE risk model. Eur J Prev Cardiol 2022;29:328–39. https://doi.org/10.1093/eurjpc/zwaa128 1169. De Bacquer D, Ueda P, Reiner Z, De Sutter J, De Smedt D, Lovic D, et al. EUROASPIRE Risk Calculator. https://www.calconic.com/calculator-widgets/euroaspire-risk-factor-% 20calculator/5f6223fab75b14001e1f3c67?layouts=true 1170. Cho SMJ, Koyama S, Honigberg MC, Surakka I, Haidermota S, Ganesh S, et al. Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study. Eur Heart J 2023;44:3456–65. https:// doi.org/10.1093/eurheartj/ehad380 1171. Iribarren C, Lu M, Jorgenson E, Martínez M, Lluis-Ganella C, Subirana I, et al. Clinical utility of multimarker genetic risk scores for prediction of incident coronary heart disease: a cohort study among over 51 000 individuals of European ancestry. Circ Cardiovasc Genet 2016;9:531–40. https://doi.org/10.1161/CIRCGENETICS.116. 001522 1172. Weintraub WS, Boden WE. Can we measurably improve the prediction of recurrent coronary artery disease events? Eur Heart J 2023;44:3466–8. https://doi.org/10.1093/ eurheartj/ehad464 1173. Park D-W, Kang D-Y, Ahn J-M, Yun S-C, Yoon Y-H, Hur S-H, et al. Routine functional testing or standard care in high-risk patients after PCI. New Engl J Med 2022;387: 905–15. https://doi.org/10.1056/NEJMoa2208335 1174. Chan M, Ridley L, Dunn DJ, Tian DH, Liou K, Ozdirik J, et al. A systematic review and meta-analysis of multidetector computed tomography in the assessment of coronary artery bypass grafts. Int J Cardiol 2016;221:898–905. https://doi.org/10.1016/j.ijcard. 2016.06.264 1175. Li Y, Yu M, Li W, Lu Z, Wei M, Zhang J. Third generation dual-source CT enables accurate diagnosis of coronary restenosis in all size stents with low radiation dose and preserved image quality. Eur Radiol 2018;28:2647–54. https://doi.org/10.1007/ s00330-017-5256-3 1176. Mansour HH, Alajerami YS, Abushab KM, Quffa KM. The diagnostic accuracy of coronary computed tomography angiography in patients with and without previous coronary interventions. J Med Imaging Radiat Sci 2022;53:81–6. https://doi.org/10.1016/j. jmir.2021.10.005 1177. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28: 616–26. https://doi.org/10.1016/0735-1097(96)00206-9 1178. Barbero U, Iannaccone M, d’Ascenzo F, Barbero C, Mohamed A, Annone U, et al. 64 Slice-coronary computed tomography sensitivity and specificity in the evaluation of coronary artery bypass graft stenosis: a meta-analysis. Int J Cardiol 2016;216:52–7. https://doi.org/10.1016/j.ijcard.2016.04.156 1179. de Winter RW, Rahman MS, van Diemen PA, Schumacher SP, Jukema RA, Somsen YBO, et al. Diagnostic and management strategies in patients with late recurrent angina after coronary artery bypass grafting. Curr Cardiol Rep 2022;24:1309–25. https:// doi.org/10.1007/s11886-022-01746-w 1180. Zellweger MJ, Hachamovitch R, Kang X, Hayes SW, Friedman JD, Germano G, et al. Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease. J Nucl Cardiol 2009;16:193–200. https://doi.org/10.1007/s12350-008-9016-2 1181. Al-Lamee RK, Shun-Shin MJ, Howard JP, Nowbar AN, Rajkumar C, Thompson D, et al. Dobutamine stress echocardiography ischemia as a predictor of the placebocontrolled efficacy of percutaneous coronary intervention in stable coronary artery disease: the stress echocardiography-stratified analysis of ORBITA. Circulation 2019; 140:1971–80. https://doi.org/10.1161/CIRCULATIONAHA.119.042918 1182. Stefanini GG, Alfonso F, Barbato E, Byrne R, Capodanno D, Colleran R, et al. Management of myocardial revascularisation failure: an expert consensus document Downloaded from academic.oup.com/eurheartj/article/45/36/3415/7743115 by guest on 07 October 2026